Click for best price
Dilated Cardiomyopathy Market Size, Share 2023
| Market size in 2022 |
US$ 174.7 million
|
Forecast Market size by 2029 |
US$ 269.9 million
|
| Growth Rate |
CAGR of 6.4% |
Number of Pages |
63 Pages |
The global Dilated Cardiomyopathy market was valued at US$ 174.7 million in 2022 and is projected to reach US$ 269.9 million by 2029, at a CAGR of 6.4% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Dilated Cardiomyopathy (DCM) refers to the cardiac hypertrophy, cannot effectively pump blood.
This report aims to provide a comprehensive presentation of the global market for Dilated Cardiomyopathy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dilated Cardiomyopathy. This report contains market size and forecasts of Dilated Cardiomyopathy in global, including the following market information:
- Global Dilated Cardiomyopathy Market Revenue, 2018-2023, 2024-2030, ($ millions)
- Global top five companies in 2022 (%)
Dilated Cardiomyopathy (DCM) is due to genetic or other disease caused by a heart disease, it respectively affect the ventricles of the heart and heart, the inferior vena chamber and the upper Chambers of the heart.
We surveyed the Dilated Cardiomyopathy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Dilated Cardiomyopathy Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Dilated Cardiomyopathy Market Segment Percentages, by Type, 2022 (%)
- Diuretics
- Angiotensin-Converting Enzyme (ACE) Inhibitors
- Angiotensin II Receptor Blockers (ARBs)
- Beta Blockers
- Blood Thinning Medications
- Cardiac Glycosides
Global Dilated Cardiomyopathy Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Dilated Cardiomyopathy Market Segment Percentages, by Application, 2022 (%)
Global Dilated Cardiomyopathy Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Dilated Cardiomyopathy Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Dilated Cardiomyopathy revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Dilated Cardiomyopathy revenues share in global market, 2022 (%)
Key players include:
- Zensun
- Capricor Therapeutics
- Vericel
- t2cure GmbH
- MyoKardia
- Kasiak Research
Outline of Major Chapters:
Chapter 1: Introduces the definition of Dilated Cardiomyopathy, market overview.
Chapter 2: Global Dilated Cardiomyopathy market size in revenue.
Chapter 3: Detailed analysis of Dilated Cardiomyopathy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Dilated Cardiomyopathy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Dilated Cardiomyopathy Market, Global Outlook and Forecast 2023-2030 |
| Market size in 2022 |
US$ 174.7 million
|
| Forecast Market size by 2029 |
US$ 269.9 million
|
| Growth Rate |
CAGR of 6.4% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
63 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Dilated Cardiomyopathy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Dilated Cardiomyopathy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Dilated Cardiomyopathy Overall Market Size
2.1 Global Dilated Cardiomyopathy Market Size: 2022 VS 2030
2.2 Global Dilated Cardiomyopathy Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Dilated Cardiomyopathy Players in Global Market
3.2 Top Global Dilated Cardiomyopathy Companies Ranked by Revenue
3.3 Global Dilated Cardiomyopathy Revenue by Companies
3.4 Top 3 and Top 5 Dilated Cardiomyopathy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Dilated Cardiomyopathy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Dilated Cardiomyopathy Players in Global Market
3.6.1 List of Global Tier 1 Dilated Cardiomyopathy Companies
3.6.2 List of Global Tier 2 and Tier 3 Dilated Cardiomyopathy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Dilated Cardiomyopathy Market Size Markets, 2022 & 2030
4.1.2 Diuretics
4.1.3 Angiotensin-Converting Enzyme (ACE) Inhibitors
4.1.4 Angiotensin II Receptor Blockers (ARBs)
4.1.5 Beta Blockers
4.1.6 Blood Thinning Medications
4.1.7 Cardiac Glycosides
4.2 By Type - Global Dilated Cardiomyopathy Revenue & Forecasts
4.2.1 By Type - Global Dilated Cardiomyopathy Revenue, 2018-2023
4.2.2 By Type - Global Dilated Cardiomyopathy Revenue, 2024-2030
4.2.3 By Type - Global Dilated Cardiomyopathy Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Dilated Cardiomyopathy Market Size, 2022 & 2030
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Dilated Cardiomyopathy Revenue & Forecasts
5.2.1 By Application - Global Dilated Cardiomyopathy Revenue, 2018-2023
5.2.2 By Application - Global Dilated Cardiomyopathy Revenue, 2024-2030
5.2.3 By Application - Global Dilated Cardiomyopathy Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Dilated Cardiomyopathy Market Size, 2022 & 2030
6.2 By Region - Global Dilated Cardiomyopathy Revenue & Forecasts
6.2.1 By Region - Global Dilated Cardiomyopathy Revenue, 2018-2023
6.2.2 By Region - Global Dilated Cardiomyopathy Revenue, 2024-2030
6.2.3 By Region - Global Dilated Cardiomyopathy Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Dilated Cardiomyopathy Revenue, 2018-2030
6.3.2 US Dilated Cardiomyopathy Market Size, 2018-2030
6.3.3 Canada Dilated Cardiomyopathy Market Size, 2018-2030
6.3.4 Mexico Dilated Cardiomyopathy Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Dilated Cardiomyopathy Revenue, 2018-2030
6.4.2 Germany Dilated Cardiomyopathy Market Size, 2018-2030
6.4.3 France Dilated Cardiomyopathy Market Size, 2018-2030
6.4.4 U.K. Dilated Cardiomyopathy Market Size, 2018-2030
6.4.5 Italy Dilated Cardiomyopathy Market Size, 2018-2030
6.4.6 Russia Dilated Cardiomyopathy Market Size, 2018-2030
6.4.7 Nordic Countries Dilated Cardiomyopathy Market Size, 2018-2030
6.4.8 Benelux Dilated Cardiomyopathy Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Dilated Cardiomyopathy Revenue, 2018-2030
6.5.2 China Dilated Cardiomyopathy Market Size, 2018-2030
6.5.3 Japan Dilated Cardiomyopathy Market Size, 2018-2030
6.5.4 South Korea Dilated Cardiomyopathy Market Size, 2018-2030
6.5.5 Southeast Asia Dilated Cardiomyopathy Market Size, 2018-2030
6.5.6 India Dilated Cardiomyopathy Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Dilated Cardiomyopathy Revenue, 2018-2030
6.6.2 Brazil Dilated Cardiomyopathy Market Size, 2018-2030
6.6.3 Argentina Dilated Cardiomyopathy Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Dilated Cardiomyopathy Revenue, 2018-2030
6.7.2 Turkey Dilated Cardiomyopathy Market Size, 2018-2030
6.7.3 Israel Dilated Cardiomyopathy Market Size, 2018-2030
6.7.4 Saudi Arabia Dilated Cardiomyopathy Market Size, 2018-2030
6.7.5 UAE Dilated Cardiomyopathy Market Size, 2018-2030
7 Dilated Cardiomyopathy Companies Profiles
7.1 Zensun
7.1.1 Zensun Company Summary
7.1.2 Zensun Business Overview
7.1.3 Zensun Dilated Cardiomyopathy Major Product Offerings
7.1.4 Zensun Dilated Cardiomyopathy Revenue in Global Market (2018-2023)
7.1.5 Zensun Key News & Latest Developments
7.2 Capricor Therapeutics
7.2.1 Capricor Therapeutics Company Summary
7.2.2 Capricor Therapeutics Business Overview
7.2.3 Capricor Therapeutics Dilated Cardiomyopathy Major Product Offerings
7.2.4 Capricor Therapeutics Dilated Cardiomyopathy Revenue in Global Market (2018-2023)
7.2.5 Capricor Therapeutics Key News & Latest Developments
7.3 Vericel
7.3.1 Vericel Company Summary
7.3.2 Vericel Business Overview
7.3.3 Vericel Dilated Cardiomyopathy Major Product Offerings
7.3.4 Vericel Dilated Cardiomyopathy Revenue in Global Market (2018-2023)
7.3.5 Vericel Key News & Latest Developments
7.4 t2cure GmbH
7.4.1 t2cure GmbH Company Summary
7.4.2 t2cure GmbH Business Overview
7.4.3 t2cure GmbH Dilated Cardiomyopathy Major Product Offerings
7.4.4 t2cure GmbH Dilated Cardiomyopathy Revenue in Global Market (2018-2023)
7.4.5 t2cure GmbH Key News & Latest Developments
7.5 MyoKardia
7.5.1 MyoKardia Company Summary
7.5.2 MyoKardia Business Overview
7.5.3 MyoKardia Dilated Cardiomyopathy Major Product Offerings
7.5.4 MyoKardia Dilated Cardiomyopathy Revenue in Global Market (2018-2023)
7.5.5 MyoKardia Key News & Latest Developments
7.6 Kasiak Research
7.6.1 Kasiak Research Company Summary
7.6.2 Kasiak Research Business Overview
7.6.3 Kasiak Research Dilated Cardiomyopathy Major Product Offerings
7.6.4 Kasiak Research Dilated Cardiomyopathy Revenue in Global Market (2018-2023)
7.6.5 Kasiak Research Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Dilated Cardiomyopathy Market Opportunities & Trends in Global Market
Table 2. Dilated Cardiomyopathy Market Drivers in Global Market
Table 3. Dilated Cardiomyopathy Market Restraints in Global Market
Table 4. Key Players of Dilated Cardiomyopathy in Global Market
Table 5. Top Dilated Cardiomyopathy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Dilated Cardiomyopathy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Dilated Cardiomyopathy Revenue Share by Companies, 2018-2023
Table 8. Global Companies Dilated Cardiomyopathy Product Type
Table 9. List of Global Tier 1 Dilated Cardiomyopathy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Dilated Cardiomyopathy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Dilated Cardiomyopathy Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Dilated Cardiomyopathy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Dilated Cardiomyopathy Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Dilated Cardiomyopathy Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Dilated Cardiomyopathy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Dilated Cardiomyopathy Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Dilated Cardiomyopathy Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Dilated Cardiomyopathy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Dilated Cardiomyopathy Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Dilated Cardiomyopathy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Dilated Cardiomyopathy Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Dilated Cardiomyopathy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Dilated Cardiomyopathy Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Dilated Cardiomyopathy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Dilated Cardiomyopathy Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Dilated Cardiomyopathy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Dilated Cardiomyopathy Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Dilated Cardiomyopathy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Dilated Cardiomyopathy Revenue, (US$, Mn), 2024-2030
Table 30. Zensun Company Summary
Table 31. Zensun Dilated Cardiomyopathy Product Offerings
Table 32. Zensun Dilated Cardiomyopathy Revenue (US$, Mn) & (2018-2023)
Table 33. Zensun Key News & Latest Developments
Table 34. Capricor Therapeutics Company Summary
Table 35. Capricor Therapeutics Dilated Cardiomyopathy Product Offerings
Table 36. Capricor Therapeutics Dilated Cardiomyopathy Revenue (US$, Mn) & (2018-2023)
Table 37. Capricor Therapeutics Key News & Latest Developments
Table 38. Vericel Company Summary
Table 39. Vericel Dilated Cardiomyopathy Product Offerings
Table 40. Vericel Dilated Cardiomyopathy Revenue (US$, Mn) & (2018-2023)
Table 41. Vericel Key News & Latest Developments
Table 42. t2cure GmbH Company Summary
Table 43. t2cure GmbH Dilated Cardiomyopathy Product Offerings
Table 44. t2cure GmbH Dilated Cardiomyopathy Revenue (US$, Mn) & (2018-2023)
Table 45. t2cure GmbH Key News & Latest Developments
Table 46. MyoKardia Company Summary
Table 47. MyoKardia Dilated Cardiomyopathy Product Offerings
Table 48. MyoKardia Dilated Cardiomyopathy Revenue (US$, Mn) & (2018-2023)
Table 49. MyoKardia Key News & Latest Developments
Table 50. Kasiak Research Company Summary
Table 51. Kasiak Research Dilated Cardiomyopathy Product Offerings
Table 52. Kasiak Research Dilated Cardiomyopathy Revenue (US$, Mn) & (2018-2023)
Table 53. Kasiak Research Key News & Latest Developments
List of Figures
Figure 1. Dilated Cardiomyopathy Segment by Type in 2022
Figure 2. Dilated Cardiomyopathy Segment by Application in 2022
Figure 3. Global Dilated Cardiomyopathy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Dilated Cardiomyopathy Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Dilated Cardiomyopathy Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Dilated Cardiomyopathy Revenue in 2022
Figure 8. By Type - Global Dilated Cardiomyopathy Revenue Market Share, 2018-2030
Figure 9. By Application - Global Dilated Cardiomyopathy Revenue Market Share, 2018-2030
Figure 10. By Type - Global Dilated Cardiomyopathy Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Dilated Cardiomyopathy Revenue Market Share, 2018-2030
Figure 12. By Application - Global Dilated Cardiomyopathy Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Dilated Cardiomyopathy Revenue Market Share, 2018-2030
Figure 14. By Region - Global Dilated Cardiomyopathy Revenue Market Share, 2018-2030
Figure 15. By Country - North America Dilated Cardiomyopathy Revenue Market Share, 2018-2030
Figure 16. US Dilated Cardiomyopathy Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Dilated Cardiomyopathy Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Dilated Cardiomyopathy Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Dilated Cardiomyopathy Revenue Market Share, 2018-2030
Figure 20. Germany Dilated Cardiomyopathy Revenue, (US$, Mn), 2018-2030
Figure 21. France Dilated Cardiomyopathy Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Dilated Cardiomyopathy Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Dilated Cardiomyopathy Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Dilated Cardiomyopathy Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Dilated Cardiomyopathy Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Dilated Cardiomyopathy Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Dilated Cardiomyopathy Revenue Market Share, 2018-2030
Figure 28. China Dilated Cardiomyopathy Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Dilated Cardiomyopathy Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Dilated Cardiomyopathy Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Dilated Cardiomyopathy Revenue, (US$, Mn), 2018-2030
Figure 32. India Dilated Cardiomyopathy Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Dilated Cardiomyopathy Revenue Market Share, 2018-2030
Figure 34. Brazil Dilated Cardiomyopathy Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Dilated Cardiomyopathy Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Dilated Cardiomyopathy Revenue Market Share, 2018-2030
Figure 37. Turkey Dilated Cardiomyopathy Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Dilated Cardiomyopathy Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Dilated Cardiomyopathy Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Dilated Cardiomyopathy Revenue, (US$, Mn), 2018-2030
Figure 41. Zensun Dilated Cardiomyopathy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Capricor Therapeutics Dilated Cardiomyopathy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Vericel Dilated Cardiomyopathy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. t2cure GmbH Dilated Cardiomyopathy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. MyoKardia Dilated Cardiomyopathy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Kasiak Research Dilated Cardiomyopathy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
